PRostate Olaparib real World Evidence Study

Trial Identifier: D0817R00049
Sponsor: AstraZeneca
Start Date: October 2023
Primary Completion Date: October 2028
Study Completion Date: October 2028
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France AMIENS, France
France ANGERS CEDEX 9, France
France ANTONY, France
France ARGENTEUIL, France
France AVIGNON, France
France BESANCON, France
France CHALLES LES EAUX, France
France CHAMBRAY LES TOURS, France
France CHAMPIGNY SUR MARNE, France
France CLERMONT-FERRAND CEDEX 1, France
France COMPIEGNE CEDEX, France
France CRETEIL, France
France EPAGNY METZ TESSY, France
France ERMONT, France
France FORT DE FRANCE, France
France FREJUS CEDEX, France
France GRENOBLE CEDEX 9, France
France LE CHESNAY, France
France LE COUDRAY, France
France LE MANS, France
France LEVALLOIS PERRET, France
France LYON, France
France LYON CEDEX 09, France
France MANTES LA JOLIE, France
France MARSEILLE, France
France MORLAIX, France
France NANCY, France
France NANTES, France
France NICE CEDEX 2, France
France ORL ANS, France
France PARIS, France
France POINTE A PITRE, France
France POITIERS, France
France PONTOISE, France
France QUINT FONSEGRIVES, France
France ROUEN, France
France SAINT DENIS- LA REUNION, France
France SAINT DOULCHARD, France
France SAINT MANDE, France
France SAINT-ETIENNE, France
France SAINT-ETIENNE CEDEX 1, France
France ST NAZAIRE, France
France STRASBOURG, France
France SURESNES, France
France TOURS, France
France VANNES, France
France VANTOUX, France